107
Views
109
CrossRef citations to date
0
Altmetric
Review Papers

Vascular prosthetic Graft Infection: Epidemiology, Bacteriology, Pathogenesis and Treatment

, , , , , , , , , , , , , , , & show all
Pages 238-247 | Published online: 14 Mar 2016

References

  • Schmitt D. D., Seabrook G. R., Bandyk D. F., Towne J. B. Graft excision and extra-anatomic revascularization: the treatment of choice for septic aortic prosthesis. J Cardiovasc Surg, 1990, 31: 327–332.
  • Yeager R. A., Moneta G. L., Taylor L. M., Harris E. J., McConnel D. B., Porter J. M. Improving surgical and limb salvage in patients with aortic graft infection. Am J Surg, 1990, 159: 466–469.
  • Torsello G., Sandmann W., Ghert A., Jungblut R. In situ replacement of infected vascular prosthesis with rifampicin-soaked vascular grafts: early results. J Vasc Surg, 1993, 17: 768–773.
  • Clagett G. P., Bowers B. L., Lopez-Viego M. A., Rossi M. B., Valentine R. J., Myers S. I. et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg, 1993, 218: 239–49.
  • Ehrenfeld W. K., Wilbur B. G., Olcott C. N. IV, Stoney R. J. Autogenous tissue reconstruction in management of infected prosthetic grafts. Surgery, 1979, 85: 82–92.
  • Quiñones-Baldrich W. J., Gelabert H. A. Autogenous tissue reconstruction in management of aortoiliofemoral graft infection. Ann Vasc Surg, 1990, 4: 223–8.
  • Kieffer E., Bahnini A., Koskas F., Ruotolo C., LeBlevec D., Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg, 1993, 17: 349–56.
  • Koskas F., Goëau-Brissonnière O., Nicolas M. H., Bacourt F., Kieffer E. Arteries from human beings are less infectable by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg, 1996, 23: 472–6.
  • Hayes P. D., Nasim A., London N. J., Sayers R. D., Barrie W. W., Bell P. R., Naylor A. R. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg, 1999, 30: 92–98.
  • Bandyk D. F. Vascular graft infections: epidemiology, microbiology, pathogenesis, and prevention. In: Bernhard V. M., Towne J. B. (eds.). Complications in Vascular Surgery. St Louis, quality Medical Publishing, 1991: 223–234.
  • Szylagyi D. E., Smith R. F., Elliott J. P., Vrandecic M. P. Infection in arterial reconstruction with synthetic grafts. Ann Surg, 1972, 176: 321–333.
  • Bunt T. J. Synthetic vascular graft infections. Surgery, 1983, 93: 733–746.
  • Bandyk D. F. Aortic graft infection. Sem Vasc Surg, 1990, 3: 122.
  • Association Universitaire de Recherche en Chirurgie, Goeau-Brissonnére O, Doyon F. et coll. étude prospective de 597 prothèses aorto-femorales: résultats préliminaires. 4e Congres international sur la Prophylaxie des infections. Nice, 6–7 Mai 1996.
  • Goldstone J., Moore W. S. Infection in vascular prostheses: clinical manifestations and surgical management. Am J Surg, 1974, 128: 225–233.
  • Bandyk D. F. Infection in prosthetic vascular grafts. In: Rutherford RB. Vascular Surgery. 5th ed. Saunders, vol. 1, 733–751.
  • Chih-Chang C., Williams D. F. Effects of physical configuration and chemical structure of materials on bacterial adhesion. Am J Surg, 1984, 147: 197–204.
  • Bandyk D. F., Berni G. A., Thiele B. L., Towne J. B. Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg, 1984, 8: 303–308.
  • Arciola C. R., Montanaro L., Baldassarri L., Borsetti E., Cavedagna D., Donati E. Slime production by Staphylococci isolated from prosthesis-associated infections. New Microbiol, 1999, 22 (4): 337–341.
  • Bandyk D. F., Bergamini T. M., Kinney E. V., Seabrook G. R., Towne J. B. In situ replacement of vascular prostheses infected by bacterial microfilms. J Vasc Surg, 1991, 13: 575–583.
  • Sugarman B. In vitro adherence of bacteria to prosthetic grafts. Infection, 1982, 10: 9–12.
  • Boyce B. Physical characteristics of expanded polytetrafluore-thylene grafts. Biologic and synthetic vascular prostheses, Ed. James Stanley 1982, Grune and Stratton, Inc: 553–561.
  • Bergamini T. M., Bandyk F. B., Govostis D. et al. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg, 1988, 7: 21–30.
  • Prewett A. Design and development of an antimicrobial vascular graft. Satellite Symposium European Vascular Course. Amsterdam, March 2000.
  • Vicaretti M., Hawthorne W., Ao P. Y., Fletcher J. P. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatine sealed Dacron graft reduce the incidence of subsequent infection ? Int Angiol, 1999, 18 (3): 225232.
  • Benaerts P. J., Ridler B. M., Vercaeren P., Thompson J. F., Campbell W. B. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc Surg, 1999, 7 (4): 447–450.
  • Seeger J. M., Pretus H. A., Burress Welborn M. et al. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg, 2000, 32: 451–461.
  • Coselli J. S., Crawford E. S., Williams T. W. et al. Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flap. Ann Thorac Surg, 1990, 50: 868–881.
  • Coggia M., Goeau-Brissonnière O., Leflon V. et al. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg, 2001, 15: 421–429.
  • Nevelsteen A., Lacroix H., Suy R. Autogenous reconstruction with the lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg, 1995, 22: 129–134.
  • Valentine R. J., Clagett G. P. Aortic graft infections: replacement with autogenous vein. Cardiovasc Surg, 2001, 9 (5): 419–425.
  • Zwiscenberg J. B., Shalaby T. Z., Conti V. E. Viable cryopre-served aortic homograft for aortic valve endocarditis and anular abscesses. Ann Thorac Surg, 1989, 48: 365–370.
  • Kieffer E., Bahnini A., Koskas F. et al. In situ allograft replacement of infected infrarenal aortic prosthetic graft: results in forty-three patients. J Vasc Surg, 1993, 17: 349–356.
  • Koskas F., Plissonier D., Bahnini A., Ruotolo C., Kieffer E. In situ arterial allografting for aorto-iliac graft infection: a 6-year experience. Cardiovasc Surg, 1996, 4: 495–499.
  • Gournier J. P., Adam M., Favre J. P. et al. Cryopreserved arterial homografts: preliminary study. Ann Vasc Surg, 1993, 7: 503511.
  • Chiesa R., Astore D., Piccolo G. et al. Fresh and cryopreserved arterial homograft in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg, 1998, 12: 457–462.
  • Knosalla C., Goeau-Brissonniere O., Leflon V., Bruneval P., Eugene M., Pechere J. C., Koskas F., Nicolas M. H., Leschi J. P., Gerota J., Kieffer E. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg, 1998, 27 (4): 689–698.
  • Camiade C., Goldschmidt P., Koskas F., Ricco J. B., Jarraya M., Gerota J., Kieffer E. Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses. Ann Vasc Surg, 2001, 15 (2): 186–196.
  • Plissonnier D., Nochy D., Poncet P., Mandet C., Hinglais N., Bariety J. et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation, 1995, 60: 41424.
  • Schmitz-Rixen T., Megerman J., Colvin R. B., Williams A. M., Abbott W. M. Immunosuppressive treatment of aortic allografts. J Vasc Surg, 1988, 7: 82–92.
  • Vischjager M., Van Gulik T. M., Van Marle J., Pfaffendorf M., Jacobs M. J. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. J Vasc Surg, 1996, 24: 876–82.
  • Zwischenberger J. B., Shalaby T. Z., Conti V. R. Viable cryopre-served aortic homograft for aortic valve endocarditis and annular abscesses. Ann Thorac Surg, 1989, 48: 365–70.
  • Vogt P. R., von Segesser L. K., Goffin Y., Niederhäuser U., Genoni M., Künzli A. et al. Eradication of aortic infections with the use of cryopreserved arterial homografts. Ann Thorac Surg, R. Chiesa 1996, 62: 640–5.
  • LESÈCHE G., CASTIER Y., PETIT M. D., BERTRAND P., KITZIS M., MUSSOT S., BESNARD M., CERCEAU O. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg, 2001, 34: 616–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.